Receptor.AI
AI-accelerated drug discovery SaaS platform performing structure-based screening against human proteins and estimating safety and pharmacokinetics of compounds using neural networks.
Where Receptor.AI ranks
Current edition · updated Oct 20, 2026About Receptor.AI
AI-accelerated drug discovery SaaS platform performing structure-based screening against human proteins and estimating safety and pharmacokinetics of compounds using neural networks.
Industries served
Products
AI drug design platform with dedicated sub-platforms for Small Molecules, Peptides, and Proximity Inducers, combining 40+ experimentally validated AI methodologies for molecular...
Security and compliance
As reported by Receptor.AI. Ask for audit reports before you buy.
- Software security
- Data networking security
- Information storage security
- Commercially acceptable means for personal data protection
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Receptor.AI